Skip to main content
SpringerLink
Log in

Prevention of Endometriosis

  • Chapter
  • First Online:
Book cover Endometriosis

Abstract

There is an association between the presence of endometriosis and common autoimmune and atopic diseases and some of the cancers. There are also concerns about the risk for birth defects in the children of women with endometriosis. Prevention of endometriosis may also reduce the risk for these other health problems and their sequelae. To be able to prevent or delay the development of endometriosis and hopefully other associated comorbidities, risk factors for endometriosis should be defined. Exposure to environmental chemicals recently has been proposed to contribute to several gynecologic pathologies including endometriosis, especially when exposures occur during critical periods of development. Although potential role in the pathogenesis of endometriosis has not been established, exposure to certain endocrine-disrupting chemicals is shown to be higher in women affected by endometriosis compared to women without the disease. Although there is extensive scientific and clinical data applicable to endometriosis when it is regarded as a systemic inflammatory, endocrine, and immunological disease, the prevention of endometriosis per se, have not been addressed fully in the medical literature.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ballweg ML. Prevention of endometriosis: it might be possible. In: Matalliotakis I, Arici A, editors. New Developments in Endometriosis. CreateSpace; 2011. p. 1–44.

    Google Scholar 

  2. Ballweg ML. Impact of endometriosis on women’s health: comparative historical data show that the earlier the onset, the more severe the disease. Best Pract Res Clin Obstet Gynaecol. 2004;18(2):201–18.

    PubMed  Google Scholar 

  3. Biberoglu K. Prevention of endometriosis: Is it possible? J Endometriosis. 2012;4(3):129–30.

    Google Scholar 

  4. Peterson CM, Johnstone EB, Hammoud AO, Stanford JB, Varner MW, Kennedy A, et al. ENDO Study Working Group. Risk factors associated with endometriosis: importance of study population for characterizing disease in the ENDO study. Am J Obstet Gynecol. 2013;208:451. e1–11.

    PubMed Central  PubMed  Google Scholar 

  5. Matalliotakis IM, Cakmak H, Fragouli YG, Goumenou AG, Mahutte NG, Arici A. Epidemiological characteristics in women with and without endometriosis in the Yale series. Arch Gynecol Obstet. 2008;277:389–93.

    PubMed  Google Scholar 

  6. Vercellini P, De Giorgi O, Aimi G, Panazza S, Uglietti A, Crosignani PG. Menstrual characteristics in women with and without endometriosis. Obstet Gynecol. 1997;90:264–8.

    CAS  PubMed  Google Scholar 

  7. Nouri K, Ott J, Krupitz B, Huber JC, Wenzl R. Family incidence of endometriosis in first-, second-, and third-degree relatives: case–control study. Reprod Biol Endocrinol. 2010;8:85.

    PubMed Central  PubMed  Google Scholar 

  8. Filer RB, Wu CH. Coitus during menses: its effect on endometriosis and pelvic inflammatory disease. J Reprod Med. 1989;34:887–90.

    CAS  PubMed  Google Scholar 

  9. Cramer DW, Wilson E, Stillman RJ, Berger MJ, Belisle S, Schiff I, et al. The relation of endometriosis to menstrual characteristics, smoking, and exercise. JAMA. 1986;255:1904–8.

    CAS  PubMed  Google Scholar 

  10. Woodworth SH, Singh M, Yussman MA, Sanfilippo JS, Cook CL, Lincoln SR. A prospective study on the association between red hair color and endometriosis in infertile patients. Fertil Steril. 1995;64:651–2.

    CAS  PubMed  Google Scholar 

  11. Somigliana E, Vigano P, Abbiati A, Gentilini D, Parazzini F, Benaglia L, et al. ’Here comes the sun’: pigmentary traits and sun habits in women with endometriosis. Hum Reprod. 2010;25:728–33.

    PubMed  Google Scholar 

  12. Ewens KG, Stewart DR, Ankener W, Urbanek M, McAllister JM, Chen C, et al. Family-based analysis of candidate genes for polycystic ovary syndrome. J Clin Endocrinol Metab. 2010;95:2306–15.

    CAS  PubMed Central  PubMed  Google Scholar 

  13. Treloar SA, Wicks J, Nyholt DR, Montgomery GW, Bahlo M, Smith V, et al. Genomewide linkage study in 1176 affected sister pair families identifies a significant susceptibility locus for endometriosis on chromosome 10q26. Am J Hum Genet. 2005;77:365–76.

    CAS  PubMed Central  PubMed  Google Scholar 

  14. Matalliotakis IM, Arici A, Cakmak H, Goumenou AG, Koumantakis G, Mahutte NG. Familial aggregation of endometriosis in the Yale Series. Arch Gynecol Obstet. 2008;278(6):507–11.

    PubMed  Google Scholar 

  15. Layman LC. The genetic basis of female reproductive disorders: etiology and clinical testing. Mol Cell Endocrinol. 2013;370(1–2):138–48.

    CAS  PubMed Central  PubMed  Google Scholar 

  16. Nnoaham KE, Webster P, Kumbang J, Kennedy SH, Zondervan KT. Is early age at menarche a risk factor for endometriosis? A systematic review and meta-analysisof case–control studies. Fertil Steril. 2012;98(3):702–12.

    PubMed Central  PubMed  Google Scholar 

  17. Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Malspeis S, Willet WC, et al. Reproductive history and endometriosis among premenopausal women. Obstet Gynec. 2004;5(1):965–74.

    Google Scholar 

  18. Treloar SA, Bell TA, Nagle CM, Purdie DM, Green AC. Early menstrual characteristics associated with subsequent diagnosis of endometriosis. Am J Obstet Gynecol. 2010;202:534. e1–6.

    PubMed  Google Scholar 

  19. Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am. 1997;24:235–58.

    CAS  PubMed  Google Scholar 

  20. Ferrero S, Anserini P, Remorgida V, Ragni N. Body mass index in endometriosis. Eur J Obstet Gynecol Reprod Biol. 2005;121:94–8.

    PubMed  Google Scholar 

  21. Hediger ML, Hartnett J, Buck Louis GM. Association of endometriosis with body size and figure. Fertil Steril. 2005;84(5):1366–74.

    PubMed Central  PubMed  Google Scholar 

  22. Shah DK, Correia KF, Vitonis AF, Missmer SA. Body size and endometriosis: results from 20 years of follow-up within the Nurses’ Health Study II prospective cohort. Hum Reprod. 2013;28:1783 [Epub ahead of print].

    PubMed Central  PubMed  Google Scholar 

  23. Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Michels KB, Hunter DJ. In utero exposures and the incidence of endometriosis. Fertil Steril. 2004;82(6):1501–8.

    PubMed  Google Scholar 

  24. Newbold R. Cellular and molecular effects of developmental exposure to diethylstilbestrol: implications for other environmental estrogens. Environ Health Perspect. 1995;103:83–7.

    CAS  PubMed Central  PubMed  Google Scholar 

  25. Noller KL, Blair PB, O’Brien PC, Melton 3rd LJ, Offord JR, Kaufman RH, et al. Increased occurrence of autoimmune disease among women exposed in utero to diethylstilbestrol. Fertil Steril. 1988;49:1080–2.

    CAS  PubMed  Google Scholar 

  26. Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nat Rev Genet. 2007;8:253–62.

    CAS  PubMed  Google Scholar 

  27. Edwards TM, Myers JP. Environmental exposures and gene regulation in disease etiology. Environ Health Perspect. 2007;115:1264–70.

    CAS  PubMed Central  PubMed  Google Scholar 

  28. Anway MD, Skinner MK. Epigenetic transgenerational actions of endocrine disruptors. Endocrinology. 2006;147:S43–9.

    CAS  PubMed  Google Scholar 

  29. Simsa P, Mihalyi A, Schoeters G, Koppen G, Kyama CM, Den Hond EM, et al. Increased exposure to dioxin-like compounds is associated with endometriosis in a case–control study in women. Reprod Biomed Online. 2010;20:681–8.

    PubMed  Google Scholar 

  30. Cobellis L, Colacurci N, Trabucco E, Carpentiero C, Grumetto L. Measurement of bisphenol A and bisphenol B levels in human blood sera from healthy and endoemtriotic women. Biomed Chromatogr. 2009;23:1186–90.

    CAS  PubMed  Google Scholar 

  31. Weuve J, Hauser R, Calafat AM, Missmer SA, Wise LA. Association of exposure to phthalates with endometriosis and uterine leiomyomata: findings from NHANES, 1999–2004. Environ Health Perspect. 2010;118:825–8.

    CAS  PubMed Central  PubMed  Google Scholar 

  32. Caserta D, Bordi G, Ciardo F, Marci R, La Rocca C, Tait S, et al. The influence of endocrine disruptors in a selected population of infertile women. Gynecol Endocrinol. 2013;29(5):444–7.

    CAS  PubMed  Google Scholar 

  33. Cummings AM, Hedge JM, Birnbaum LS. Effect of prenatal exposure to TCDD on the promotion of endometriotic lesion growth by TCDD in adult female rats and mice. Toxicol Sci. 1999;52:45–9.

    CAS  PubMed  Google Scholar 

  34. Cummings AM, Metcalf JL, Birnbaum L. Promotion of endometriosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats and mice: time-dose dependence and species comparison. Toxicol Appl Pharmacol. 1996;138:131–9.

    CAS  PubMed  Google Scholar 

  35. Nayyar T, Bruner-Tran KL, Piestrzeniewicz-Ulanska D, Osteen KG. Developmental exposure of mice to TCDD elicits a similar uterine phenotype in adult animals as observed in women with endometriosis. Reprod Toxicol. 2007;23:326–36.

    CAS  PubMed Central  PubMed  Google Scholar 

  36. Mueller MD, Vigne JL, Streich M, Tee MK, Raio L, Dreher E, et al. 2,3,7,8-Tetrachlorodibenzo-p-dioxin increases glycodelin gene and protein expression in human endometrium. J Clin Endocrinol Metab. 2005;90:4809–15.

    CAS  PubMed  Google Scholar 

  37. Dinulescu DM, Ince TA, Quade BJ, Shafer SA, Crowley D, Jacks T. Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med. 2005;11:63–70.

    CAS  PubMed  Google Scholar 

  38. Maia Jr H, Haddad C, Coelho G, Casoy J. Role of inflammation and aromatase expression in the eutopic endometrium and its relationship with the development of endometriosis. Womens Health (Lond Engl). 2012;8(6):647–58.

    CAS  Google Scholar 

  39. Dassen H, Punyadeera C, Kamps R, Delvoux B, Van Langendonckt A, Donnez J, et al. Estrogen metabolizing enzymes in endometrium and endometriosis. Hum Reprod. 2007;22:3148–58.

    CAS  PubMed  Google Scholar 

  40. Marino JL, Holt VL, Chen C, Davis S. Lifetime occupational history and risk of endometriosis. Scand J Work Environ Health. 2009;35(3):233–40.

    PubMed Central  PubMed  Google Scholar 

  41. Zhong Y, Carmella SG, Upadhyaya P, Hochalter JB, Rauch D, Oliver A, et al. Immediate consequences of cigarette smoking: rapid formation of polycyclic aromatic hydrocarbon diol epoxides. Chem Res Toxicol. 2011;24:246–52.

    CAS  PubMed Central  PubMed  Google Scholar 

  42. Sadeu JC, Hughes CL, Agarwal S, Foster WG. Alcohol, drugs, caffeine, tobacco, and environmental contaminant exposure: reproductive health consequences and clinical implications. Crit Rev Toxicol. 2010;40:633–52.

    CAS  PubMed  Google Scholar 

  43. Kvaskoff M, Bijon A, Clavel-Chapelon F, Mesrine S, Boutron-Ruault MC. Childhood and adolescent exposures and the risk of endometriosis. Epidemiology. 2013;24(2):261–9.

    PubMed  Google Scholar 

  44. Chapron C, Souza C, de Ziegler D, Lafay-Pillet MC, Ngô C, Bijaoui G, et al. Smoking habits of 411 women with histologically proven endometriosis and 567 unaffected women. Fertil Steril. 2010;94(6):2353–5.

    PubMed  Google Scholar 

  45. McLeod BS, Retzloff MG. Epidemiology of endometriosis: an assessment of risk factors. Clin Obstet Gynecol. 2010;53(2):389–96.

    PubMed  Google Scholar 

  46. Olovsson M. Immunological aspects of endometriosis: an update. Am J Reprod Immunol. 2011;66:101–4.

    PubMed  Google Scholar 

  47. Matarese G, De Placido G, Nikas Y, Alviggi C. Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease? Trends Mol Med. 2003;9:223–8.

    CAS  PubMed  Google Scholar 

  48. Kyama CM, Debrock S, Mwenda JM, D’ Hooghe TM. Potential involvement of the immune system in the development of endometriosis. Reprod Biol Endocrinol. 2003;1(123):1–9.

    Google Scholar 

  49. Mabray CR, Burditt ML, Martin TL, Jaynes CR, Hayes JR. Treatment of common gynecologic-endocrinologic symptoms by allergy management procedures. Obstet Gynecol. 1982;59:560–4.

    CAS  PubMed  Google Scholar 

  50. Sinaii N, Cleary SD, Ballweg ML, Nieman LK, Stratton P. High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. Hum Reprod. 2002;17:2715–24.

    CAS  PubMed  Google Scholar 

  51. Matalliotakis I, Cakmak H, Matalliotakis M, Kappou D, Arıcı A. High rate of allergies among women with endometriosis. J Obstet Gynaecol. 2012;32(3):291–3.

    CAS  PubMed  Google Scholar 

  52. Hever A, Roth RB, Hevezi P, Marin ME, Acosta JA, Acosta H, et al. Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator. Proc Natl Acad Sci U S A. 2007;104:12451–6.

    CAS  PubMed Central  PubMed  Google Scholar 

  53. Christofolini DM, Cavalheiro CM, Teles JS, Lerner TG, Brandes A, Bianco B, et al. Promoter -817C>T variant of B lymphocyte stimulator gene (BLyS) and susceptibility to endometriosis-related infertility and idiopathic infertility in Brazilian population. Scand J Immunol. 2011;74(6):628–31.

    CAS  PubMed  Google Scholar 

  54. González-Ramos R, Defrère S, Devoto L. Nuclear factor-kappaB: a main regulator of inflammation and cell survival in endometriosis pathophysiology. Fertil Steril. 2012;98(3):520–8.

    PubMed  Google Scholar 

  55. Keller JJ, Liu SP, Lin HC. A case–control study on the association between rheumatoid arthritis and bladder pain syndrome/interstitial cystitis. Neurourol Urodyn. 2013;32(7):980–5.

    Google Scholar 

  56. Tietjen GE, Bushnell CD, Herial NA, Utley C, White L, Hafeez F. Endometriosis is associated with prevalence of comorbid conditions in migraine. Headache. 2007;47(7):1069–78.

    PubMed  Google Scholar 

  57. Seaman SE, Ballard KD, Wright JT, de Vries CS. Endometriosis and its coexistence with irritable bowel syndrome and pelvic inflammatory disease: findings from a national case–control study- part 2. BJOG. 2008;115:1392–6.

    CAS  PubMed  Google Scholar 

  58. Smorgick N, Marsh CA, As-Sanie S, Smith YR, Quint EH. Prevalence of pain syndromes, mood conditions, and asthma in adolescents and young women with endometriosis. J Pediatr Adolesc Gynecol. 2013;26(3):171–5.

    PubMed  Google Scholar 

  59. Issa B, Onon TS, Agrawal A, Shekhar C, Morris J, Hamdy S, et al. Visceral hypersensitivity in endometriosis:a new target for treatment? Gut. 2012;61:367–72.

    CAS  PubMed  Google Scholar 

  60. Butrick CW. Patients with chronic pelvic pain: endometriosis or interstitial cystitis/painful bladder syndrome? JSLS. 2007;11:182–9.

    PubMed Central  PubMed  Google Scholar 

  61. Ferrero S, Pretta S, Bertoldi S, Anserini P, Remorgida V, Del Sette M, et al. Increased frequency of migraine among women with endometriosis. Hum Reprod. 2004;19:2927–32.

    CAS  PubMed  Google Scholar 

  62. Tamburro S, Canis M, Albuisson E, Dechelotte P, Darcha C, Mage G. Expression of transforming growth factor β1 in nerve fibers is related to dysmenorrhea and laparoscopic appearance of endometriotic implants. Fertil Steril. 2003;80:1131–6.

    PubMed  Google Scholar 

  63. Kempuraj D, Papadopoulou N, Stanford EJ, Christodoulou S, Madhappan B, Sant GR, et al. Increased numbers of activated mast cells in endometriosis lesions positive for corticotropin releasing hormone and urocortin. Am J Reprod Immunol. 2004;52:267–75.

    PubMed  Google Scholar 

  64. Theoharides TC. Mast cells and stress—a psychoneuroimmunological perspective. J Clin Psychopharmacol. 2002;22:103–8.

    CAS  PubMed  Google Scholar 

  65. Laufer MR, Sanfilippo J, Rose G. Adolescent endometriosis: diagnosis and treatment approaches. J Pediatr Adolesc Gynecol. 2003;16:S3.

    PubMed  Google Scholar 

  66. Bricou A, Batt RE, Chapron C. Peritoneal fluid flow influences anatomical distribution of endometriotic lesions: Why Sampson seems to be right. Eur J Obstet Gynecol Reprod Biol. 2008;138:127.

    PubMed  Google Scholar 

  67. Mok-Lin EY, Wolfberg A, Hollinquist H, Laufer MR. Endometriosis in a patient with Mayer–Rokitansky–Küster–Hauser syndrome and complete uterine agenesis: evidence to support the theory of coelomic metaplasia. J Pediatr Adolesc Gynecol. 2010;23(1):e35–7.

    PubMed  Google Scholar 

  68. Uğur M, Turan C, Mungan T, Kuşçu E, Senöz S, Ağiş HT, et al. Endometriosis in association with müllerian anomalies. Gynecol Obstet Invest. 1995;40(4):261–4.

    PubMed  Google Scholar 

  69. Nasu K, Okamoto M, Nishida M, Narahara H. Endometriosis of the perineum. J Obstet Gynaecol Res. 2013;39(5):1095–7.

    PubMed  Google Scholar 

  70. Emre A, Akbulut S, Yilmaz M, Bozdag Z. Laparoscopic trocar port site endometriosis: a case report and brief literature review. Int Surg. 2012;97(2):135–9.

    PubMed Central  PubMed  Google Scholar 

  71. Horton JD, Dezee KJ, Ahnfeldt EP, Wagner M. Abdominal wall endometriosis: a surgeon’s perspective and review of 445 cases. Am J Surg. 2008;196(2):207–12.

    PubMed  Google Scholar 

  72. Odobasic A, Pasic A, Iljazovic-Latifagic E, Arnautalic L, Odobasic A, Idrizovic E, et al. Perineal endometriosis: a case report and review of the literature. Tech Coloproctol. 2010;14 Suppl 1:S25–7.

    PubMed  Google Scholar 

  73. Nominato NS, Prates LF, Lauar I, Morais J, Maia L, Geber S. Caesarean section greatly increases risk of scar endometriosis. Eur J Obstet Gynecol Reprod Biol. 2010;152(1):83–5.

    PubMed  Google Scholar 

  74. Schweppe KW, Ring D. Peritoneal defects and the development of endometriosis in relation to the timing of endoscopic surgery during the menstrual cycle. Fertil Steril. 2002;78(4):763–6.

    PubMed  Google Scholar 

  75. Harada T, Momoeda M, Taketani Y, Hoshiai H, Terakawa N. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial. Fertil Steril. 2008;90:1583–8.

    PubMed  Google Scholar 

  76. ACOG Committee Opinion. Number 310, April 2005. Endometriosis in adolescents. Obstet Gynecol. 2005;105:921–7.

    Google Scholar 

  77. Meresman GF, Auge L, Baranao RI, Lombardi E, Tesone M, Sueldo C. Oral contraceptive suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosis. Fertil Steril. 2002;77:1141–7.

    PubMed  Google Scholar 

  78. Vercellini P, Fedele L, Pietropaolo G, Frontino G, Somigliana E, Crosignani PG. Progestogens for endometriosis: forward to the past. Hum Reprod Update. 2003;9:387–96.

    CAS  PubMed  Google Scholar 

  79. Vessey MP, Villard-Mackintosh L, Painter R. Epidemiology of endometriosis in women attending family planning clinics. BMJ. 1993;306:182–4.

    CAS  PubMed Central  PubMed  Google Scholar 

  80. Fraser IS, Kovacs GT. The efficacy of non-contraceptive uses for hormonal contraceptives. Med J Aust. 2003;178:621–3.

    PubMed  Google Scholar 

  81. Parazzini F, Ferraroni M, Bocciolone L, Tozzi L, Rubessa S, La Vecchia C. Contraceptive methods and risk of pelvic endometriosis. Contraception. 1994;49:47–55.

    CAS  PubMed  Google Scholar 

  82. Italian Endometriosis Study Group. Oral contraceptive use and risk of endometriosis. BJOG. 1999;106:695–9.

    Google Scholar 

  83. Darrow SL, Vena JE, Batt RE, Zielezny MA, Michalek AM, Selman S. Menstrual cycle characteristics and the risk of endometriosis. Epidemiology. 1993;4:135–42.

    CAS  PubMed  Google Scholar 

  84. Heilier JF, Donnez J, Nackers F, Rousseau R, Verougstraete V, Rosenkranz K, et al. Environmental and host-associated risk factors in endometriosis and deep endometriotic nodules: a matched case–control study. Environ Res. 2007;103:121–9.

    CAS  PubMed  Google Scholar 

  85. Chapron C, Souza C, Borghese B, Lafay-Pillet MC, Santulli P, Bijaoui G, et al. Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis. Hum Reprod. 2011;26(8):2028–35.

    CAS  PubMed  Google Scholar 

  86. Vercellini P, Eskenazi B, Consonni D, Somigliana E, Parazzini F, Abbiati A, et al. Oral contraceptives and risk of endometriosis: a systematic review and meta-analysis. Hum Reprod Update. 2011;17:159–70.

    CAS  PubMed  Google Scholar 

  87. Di Zerega GB, Barber DL, Hodgen GD. Endometriosis: role of ovarian steroids in initiation, maintenance and suppression. Fertil Steril. 1980;33:649–53.

    Google Scholar 

  88. Seracchioli R, Mabrouk M, Frasca C, Manuzzi L, Savelli L, Venturoli S. Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial. Fertil Steril. 2010;94:464–71.

    PubMed  Google Scholar 

  89. Somigliana E, Vercellini P, Vigano P, Abbiati A, Benaglia L, Fedele L. Endometriosis and estroprogestins: the chicken or the egg causality dilemma. Fertil Steril. 2011;95:431–3.

    CAS  PubMed  Google Scholar 

  90. Hemmings R, Rivard M, Olive DL, Poliquin-Fleury J, Gagné D, Hugo P, et al. Evaluation of risk factors associated with endometriosis. Fertil Steril. 2004;81(6):1513–21.

    PubMed  Google Scholar 

  91. Moen MH. Endometriosis in women at interval sterilization. Acta Obstet Gynecol Scand. 1987;66:451–4.

    CAS  PubMed  Google Scholar 

  92. Sangi-Haghpeykar H, Poindexter AN. Epidemiology of endometriosis among parous women. Obstet Gynecol. 1995;85(6):983–92.

    CAS  PubMed  Google Scholar 

  93. Mahmood TA, Templeton A. Prevalence and genesis of endometriosis. Hum Reprod. 1991;6:544–9.

    CAS  PubMed  Google Scholar 

  94. Kirshon B, Poindexter AN. Contraception: a risk factor for endometriosis. Obstet Gynecol. 1988;71:829–31.

    CAS  PubMed  Google Scholar 

  95. Lan S, Ling L, Jianhong Z, Xijing J, Lihui W. Analysis of the levonorgestrel-releasing intrauterine system in women with endometriosis. J Int Med Res. 2013;41(3):548–58.

    PubMed  Google Scholar 

  96. ESHRE Capri Workshop Group. Intrauterine devices and intrauterine systems. Hum Reprod Update. 2008;14(3):197–208.

    Google Scholar 

  97. Vercellini P, Frontino G, De Giorgi O, Aimi G, Zaina B, Crosignani PG. Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study. Fertil Steril. 2003;80:305–9.

    PubMed  Google Scholar 

  98. Cheewadhanaraks S. Effect of tubal ligation on pelvic endometriosis externa in multiparous women with chronic pelvic pain. J Med Assoc Thai. 2004;87(7):735–9.

    PubMed  Google Scholar 

  99. Kudielka BM, Kirschbaum C. Sex differences in HPA axis responses to stress: a review. Biol Psychol. 2005;69(1):113–32.

    PubMed  Google Scholar 

  100. De Longis A, Folkman S, Lazarus RS. The impact of daily stress on health and mood: psychological and social resources as mediators. J Pers Soc Psychol. 1988;54(3):486–95.

    Google Scholar 

  101. Petrelluzzi KF, Garcia MC, Petta CA, Grassi-Kassisse DM, Spadari-Bratfisch RC. Salivary cortisol concentrations, stress and quality of life in women with endometriosis and chronic pelvic pain. Stress. 2008;11(5):390–7.

    CAS  PubMed  Google Scholar 

  102. Lima AP, Moura MD, Rosa e Silva AAM. Prolactin and cortisol levels in women with endometriosis. Braz J Med Biol Res. 2006;39(8):1121–7.

    CAS  PubMed  Google Scholar 

  103. Christodoulakos G, Augoulea A, Lambrinoudaki I, Sioulas V, Creatsas G. Pathogenesis of endometriosis: the role of defective ‘immunosurveillance’. Eur J Contracept Reprod Health Care. 2007;12(3):194–202.

    CAS  PubMed  Google Scholar 

  104. Tariverdian N, Theoharides TC, Siedentopf F, Gutiérrez G, Jeschke U, Rabinovich GA, et al. Neuroendocrine-immune disequilibrium and endometriosis: an interdisciplinary approach. Semin Immunopathol. 2007;29(2):193–210.

    PubMed Central  PubMed  Google Scholar 

  105. Cuevas M, Flores I, Thompson KJ, Ramos-Ortolaza DL, Torres-Reveron A, Appleyard CB. Stress exacerbates endometriosis manifestations and inflammatory parameters in an animal model. Reprod Sci. 2012;19(8):851–62.

    CAS  PubMed Central  PubMed  Google Scholar 

  106. Sugamata M, Ihara T, Uchiide I. Increase of activated mast cells in human endometriosis. Am J Reprod Immunol. 2005;53(3):120–5.

    PubMed  Google Scholar 

  107. Anaf V, Chapron C, Nakadi IE, De Moor V, Simonart T, Noel JC. Pain, mast cells, and nerves in peritoneal, ovarian and deep infiltrating endometriosis. Fertil Steril. 2006;86(5):1336–43.

    PubMed  Google Scholar 

  108. Fenster L, Waller K, Chen J, Hubbard AE, Windham GC, Elkin E, et al. Psychological stress in the workplace and menstrual function. Am J Epidemiol. 1999;149(2):127–34.

    CAS  PubMed  Google Scholar 

  109. Wang L, Wang X, Wang W, Chen C, Ronnennberg AG, Guang W, et al. Stress and dysmenorrhoea: a population based prospective study. Occup Environ Med. 2004;61(12):1021–6.

    CAS  PubMed Central  PubMed  Google Scholar 

  110. Gul A, Yaspar T, Ugras S. BCG vaccination to prevent implantation of endometriosis: an experimental study in rats. Eur J Obstet Gynecol Reprod Biol. 2001;98:209–12.

    CAS  PubMed  Google Scholar 

  111. Clayton RD, Duffy SR, Wilkinson N, Garry R, Jackson AM. Increase in peripheral blood mononuclear cell (PBMC)- and CD56+ cell-mediated killing of endometrial stromal cells by mycobacteria; a possible role in endometriosis immunotherapy? Hum Reprod. 2004;19(8):1886–93.

    CAS  PubMed  Google Scholar 

  112. Balasch J, Creus M, Fabregas F, Carmona F, Martínez-Román S, Manau D, et al. Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis: a pilot randomized clinical trial. Hum Reprod. 1997;12:2046–50.

    CAS  PubMed  Google Scholar 

  113. Szymanowski K, Chmaj-Wierzchowska K, Yantczenko A, Niepsuj-Biniaś J, Florek E, Opala T, et al. Endometriosis prophylaxis and treatment with the newly developed xenogenic immunomodulator RESAN in an animal model. Eur J Obstet Gynecol Reprod Biol. 2009;142(2):145–8.

    CAS  PubMed  Google Scholar 

  114. Chuang PC, Wu MH, Shoji Y, Tsai SJ. Downregulation of CD36 results in reduced phagocytic ability of peritoneal macrophages of women with endometriosis. J Pathol. 2009;219:232–41.

    CAS  PubMed  Google Scholar 

  115. Sidell N, Han SW, Parthasarathy S. Regulation and modulation of abnormal immune responses in endometriosis. Ann N Y Acad Sci. 2002;955:159–73. 99–200, 396–406.

    CAS  PubMed  Google Scholar 

  116. Jadidi-Niaragh F, Mirshafiey A. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Scand J Immunol. 2011;74:1–13.

    CAS  PubMed  Google Scholar 

  117. Elias KM, Laurence A, Davidson TS, Stephens G, Kano Y, Shevach EM, et al. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood. 2008;111:1013–20.

    CAS  PubMed Central  PubMed  Google Scholar 

  118. Wang X, Allen C, Ballow M. Retinoic acid enhances the production of IL-10 while reducing the synthesis of IL-12 and TNF-alpha from LPS-stimulated monocytes/macrophages. J Clin Immunol. 2007;27:193–200.

    PubMed  Google Scholar 

  119. Kalu E, Sumar N, Giannopoulos T, Patel P, Croucher C, Sherriff E, et al. Cytokine profiles in serum and peritoneal fluid from infertile women with and without endometriosis. J Obstet Gynaecol Res. 2007;33:490–5.

    CAS  PubMed  Google Scholar 

  120. Wieser F, Wu J, Shen Z, Taylor RN, Sidell N. Retinoic acid suppresses growth of lesions, inhibits peritoneal cytokine secretion, and promotes macrophage differentiation in an immunocompetent Mouse model of endometriosis. Fertil Steril. 2012;97(6):1430–7.

    CAS  PubMed Central  PubMed  Google Scholar 

  121. Alpay Z, Saed GM, Diamond MP. Female infertility and free radicals: potential role in adhesions and endometriosis. J Soc Gynecol Invest. 2006;13:390–8.

    CAS  Google Scholar 

  122. Portz DM, Elkins TE, White R, Warren J, Adadevoh S, Randolph J. Oxygen free radicals and pelvic adhesion formation: I. Blocking oxygen free radical toxicity to prevent adhesion formation in an endometriosis model. Int J Fertil. 1991;36:39–42.

    CAS  PubMed  Google Scholar 

  123. Del Río B, García Pedrero JM, Martínez-Campa C, Zuazua P, Lazo PS, Ramos S. Melatonin, an endogenous-specific inhibitor of estrogen receptor alpha via calmodulin. J Biol Chem. 2004;279:38294–302.

    PubMed  Google Scholar 

  124. Rato AG, Pedrero JG, Martinez MA, del Rio B, Lazo PS, Ramos S. Melatonin blocks the activation of estrogen receptor for DNA binding. FASEB J. 1999;13:857–68.

    CAS  PubMed  Google Scholar 

  125. Paul S, Sharma AV, Mahapatra PD, Bhattacharya P, Reiter RJ, Swarnakar S. Role of melatonin in regulating matrix metalloproteinase-9 via tissue inhibitors of metalloproteinase-1 during protection against endometriosis. J Pineal Res. 2008;44(4):439–49.

    CAS  PubMed  Google Scholar 

  126. Akoum A, Lemay A, McColl S, Turcot-Lemay L, Maheux R. Elevated concentration and biologic activity of monocyte chemotactic protein-1 in the peritoneal fluid of patients with endometriosis. Fertil Steril. 1996;66:17–23.

    CAS  PubMed  Google Scholar 

  127. Matsuzaki S, Canis M, Darcha C, Dallel R, Okamura K, Mage G. Cyclooxygenase-2 selective inhibitor prevents implantation of eutopic endometrium to ectopic sites in rats. Fertil Steril. 2004;82:1609–15.

    CAS  PubMed  Google Scholar 

  128. Lebovic DI, Mwenda JM, Chai DC, Mueller MD, Santi A, Fisseha S, et al. PPAR-gamma receptor ligand induces regression of endometrial explants in baboons: a prospective, randomized, placebo- and drug-controlled study. Fertil Steril. 2007;88:1108–19.

    PubMed Central  PubMed  Google Scholar 

  129. Barrier BF, Bates GW, Leland MM, Leach DA, Robinson RD, Propst AM. Efficacy of anti-tumor necrosis factor therapy in the treatment of spontaneous endometriosis in baboons. Fertil Steril. 2004;81 Suppl 1:775–9.

    CAS  PubMed  Google Scholar 

  130. Altan ZM, Denis D, Kagan D, Grund EM, Palmer SS, Nataraja SG. A long-acting tumor necrosis factor alpha-binding protein demonstrates activity in both in vitro and in vivo models of endometriosis. J Pharmacol Exp Ther. 2010;334(2):460–6.

    CAS  PubMed  Google Scholar 

  131. Khoufache K, Bazin S, Girard K, Guillemette J, Roy MC, Verreault JP, et al. Macrophage migration inhibitory factor antagonist blocks the development of endometriosis in vivo. PLoS One. 2012;7(5):e37264.

    CAS  PubMed Central  PubMed  Google Scholar 

  132. Chen PF, Luo YL, Wang W, Wang JX, Lai WY, Hu SM, et al. ISO-1, a macrophage migration inhibitory factor antagonist, inhibits airway remodeling in a murine model of chronic asthma. Mol Med. 2010;16:400–8.

    CAS  PubMed Central  PubMed  Google Scholar 

  133. Hou XQ, Gao YW, Yang ST, Wang CY, Ma ZY, Xia XZ. Role of macrophage migration inhibitory factor in influenza H5N1 virus pneumonia. Acta Virol. 2009;53:225–31.

    CAS  PubMed  Google Scholar 

  134. Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis. 2007;66(9):1137–42.

    CAS  PubMed Central  PubMed  Google Scholar 

  135. Harris HR, Chavarro JE, Malspeis S, Willett WC, Missmer SA. Dairy-food, calcium, magnesium, and vitamin D intake and endometriosis: a prospective cohort study. Am J Epidemiol. 2013;177(5):420–30.

    PubMed Central  PubMed  Google Scholar 

  136. Hartwell D, Rodbro P, Jensen SB, Thomsen K, Christiansen C. Vitamin D metabolites—relation to age, menopause and endometriosis. Scand J Clin Lab Invest. 1990;50(2):115–21.

    CAS  PubMed  Google Scholar 

  137. Somigliana E, Panina-Bordignon P, Murone S, Di Lucia P, Vercellini P, Vigano P. Vitamin D reserve is higher in women with endometriosis. Hum Reprod. 2007;22(8):2273–8.

    PubMed  Google Scholar 

  138. Agic A, Xu H, Altgassen C, Noack F, Wolfler MM, Diedrich K, et al. Relative expression of 1,25-dihydroxyvitamin D3 receptor, vitamin D 1α-hydroxylase, vitamin D 24-hydroxylase, and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers. Reprod Sci. 2007;14(5):486–97.

    CAS  PubMed  Google Scholar 

  139. Chacko SA, Song Y, Nathan L, Tinker L, de Boer IH, Tylavsky F, et al. Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunction in an ethnically diverse cohort of postmenopausal women. Diabetes Care. 2010;33(2):304–10.

    CAS  PubMed Central  PubMed  Google Scholar 

  140. D’Angelo EK, Singer HA, Rembold CM. Magnesium relaxes arterial smooth muscle by decreasing intracellular Ca2+ without changing intracellular Mg2+. J Clin Invest. 1992;89(6):1988–94.

    PubMed Central  PubMed  Google Scholar 

  141. Shand AW, Nassar N, Von Dadelszen P, Innis SM, Green TJ. Maternal vitamin D status in pregnancy and adverse pregnancy outcomes in a group at high risk for pre-eclampsia. BJOG. 2010;13:1593–8.

    Google Scholar 

  142. Gonzalez-Ramos R, Van Langendonckt A, Defrere S, Lousse JC, Mettlen M, Guillet A, et al. Agents blocking the nuclear factor-kappa B pathway are effective inhibitors of endometriosis in an in vivo experimental model. Gynecol Obstet Invest. 2008;3:174–86.

    Google Scholar 

  143. Griffin MD, Xing N, Kumar R. Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu Rev Nutr. 2003;23:117–45.

    CAS  PubMed  Google Scholar 

  144. Mariani M, Viganò P, Gentilini D, Camisa B, Caporizzo E, Di Lucia P, et al. The selective vitamin D receptor agonist, elocalcitol, reduces endometriosis development in a mouse model by inhibiting peritoneal inflammation. Hum Reprod. 2012;27(7):2010–9.

    CAS  PubMed  Google Scholar 

  145. Bruner-Tran KL, Osteen KG, Duleba AJ. Simvastatin protects against the development of endometriosis in a nude mouse model. J Clin Endocrinol Metab. 2009;94(7):2489–94.

    CAS  PubMed Central  PubMed  Google Scholar 

  146. Sokalska A, Cress A, Bruner-Tran KL, Osteen KG, Taylor HS, Ortega I, et al. Simvastatin decreases invasiveness of human endometrial stromal cells. Biol Reprod. 2012;87(1):2. 1–6.

    PubMed Central  PubMed  Google Scholar 

  147. Nothnick WB, Curry TE, Vernon MW. Immunomodulation of rat endometriotic implant growth and protein production. Am J Reprod Immun. 1994;31:151–62.

    CAS  Google Scholar 

  148. Lu D, Song H, Li Y, Clarke J, Shi G. Pentoxifylline for endometriosis. CochrDatabase Syst Rev. 2012; (1): CD007677.

    Google Scholar 

  149. Guo SW. Epigenetics of endometriosis. Mol Hum Reprod. 2009;15:587–607.

    CAS  PubMed  Google Scholar 

  150. Olive DL. Medical therapy of endometriosis. Semin Reprod Med. 2003;21:209–22.

    CAS  PubMed  Google Scholar 

  151. Moggio A, Pittatore G, Cassoni P, Marchino GL, Revelli A, Bussolati B. Sorafenib inhibits growth, migration, and angiogenic potential of ectopic endometrial mesenchymal stem cells derived from patients with endometriosis. Fertil Steril. 2012;98(6):1521–30. e2.

    CAS  PubMed  Google Scholar 

  152. Swarnakar S, Paul S. Curcumin arrests endometriosis by downregulation of matrix metalloproteinase-9 activity. Indian J Biochem Biophys. 2009;46(1):59–65.

    CAS  PubMed  Google Scholar 

  153. Jana S, Rudra DS, Paul S, Snehasikta S. Curcumin delays endometriosis development by inhibiting MMP-2 activity. Indian J Biochem Biophys. 2012;49(5):342–8.

    CAS  PubMed  Google Scholar 

  154. Kim KH, Lee EN, Park JK, Lee JR, Kim JH, Choi HJ, et al. Curcumin attenuates TNF-α-induced expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and proinflammatory cytokines in human endometriotic stromal cells. Phytother Res. 2012;26(7):1037–47.

    CAS  PubMed  Google Scholar 

  155. Xu H, Lui WT, Chu CY, Ng PS, Wang CC, Rogers MS. Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model. Hum Reprod. 2009;24:608–18.

    CAS  PubMed  Google Scholar 

  156. Hull ML, Charnock-Jones DS, Chan CL, Bruner-Tran KL, Osteen KG, Tom BD, et al. Antiangiogenic agents are effective inhibitors of endometriosis. J Clin Endocrinol Metab. 2003;88:2889–99.

    CAS  PubMed  Google Scholar 

  157. Wang CC, Xu H, Man GC, Zhang T, Chu KO, Chu CY, et al. Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice. Angiogenesis. 2013;16(1):59–69.

    CAS  PubMed  Google Scholar 

  158. Xu H, Becker CM, Lui WT, Chu CY, Davis TN, Kung AL, et al. Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo. Fertil Steril. 2011;96:1021–8.

    CAS  PubMed  Google Scholar 

  159. Athar M, Back JH, Kopelovich L, Bickers DR, Kim AL. Multiple molecular targets of resveratrol: anti-carcinogenic mechanisms. Arch Biochem Biophys. 2009;486:95–102.

    CAS  PubMed Central  PubMed  Google Scholar 

  160. Chen Y, Tseng SH. Review. Pro- and anti-angiogenesis effects of resveratrol. In Vivo. 2007;21:365–70.

    CAS  PubMed  Google Scholar 

  161. Aluyen JK, Ton QN, Tran T, Yang AE, Gottlieb HB, Bellanger RA. Resveratrol: potential as anticancer agent. J Diet Suppl. 2012;9:45–56.

    CAS  PubMed  Google Scholar 

  162. Beaudeux JL, Nivet-Antoine V, Giral P. Resveratrol: a relevant pharmacological approach for the treatment of metabolic syndrome? Curr Opin Clin Nutr Metab Care. 2010;13:729–36.

    CAS  PubMed  Google Scholar 

  163. Petrovski G, Gurusamy N, Das DK. Resveratrol in cardiovascular health and disease. Ann N Y Acad Sci. 2011;1215:22–33.

    PubMed  Google Scholar 

  164. Bruner-Tran KL, Osteen KG, Taylor HS, Sokalska A, Haines K, Duleba AJ. Resveratrol inhibits development of experimental endometriosis in vivo and reduces endometrial stromal cell invasiveness in vitro. Biol Reprod. 2011;84:106–12.

    CAS  PubMed Central  PubMed  Google Scholar 

  165. Rudzitis-Auth J, Menger MDM, Laschke MW. Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis. Hum Reprod. 2013;28(5):1339–47.

    CAS  PubMed  Google Scholar 

  166. Ricci AG, Olivares CN, Bilotas MA, Bastón JI, Singla JJ, Meresman GF, et al. Natural therapies assessment for the treatment of endometriosis. Hum Reprod. 2013;28(1):178–88.

    CAS  PubMed  Google Scholar 

  167. Wang D, Liu Y, Han J, Zai D, Ji M, Cheng W, et al. Puerarin suppresses invasion and vascularization of endometriosis tissue stimulated by 17β-estradiol. PLoS One. 2011;6(9):e25011.

    CAS  PubMed Central  PubMed  Google Scholar 

  168. Flower A, Liu JP, Lewith G, Little P, Li Q. Chinese herbal medicine for endometriosis. Cochrane Database of Systematic Reviews. 2012;(5):CD006568.

    Google Scholar 

  169. Zhao RH, Hao ZP, Zhang Y, Lian FM, Sun WW, Liu Y, Wang R, Long L, Cheng L, Ding YF, Song DR, Meng QW, Wang AM. Controlling the recurrence of pelvic endometriosis after a conservative operation: comparison between Chinese herbal medicine and western medicine. Chin J Integr Med. 2013;19(11):820–5.

    Google Scholar 

  170. Strathy JH, Molgaard CA, Coulam CB, Melton 3rd LJ. Endometriosis and infertility: a laparoscopic study of endometriosis among fertile and infertile women. Fertil Steril. 1982;38:667–72.

    CAS  PubMed  Google Scholar 

  171. Verkauf BS. The incidence, symptoms, and signs of endometriosis in fertile and infertile women. J Fla Med Assoc. 1987;74:671–5.

    CAS  PubMed  Google Scholar 

  172. Bulletti C, Montini A, Setti PL, Palagiano A, Ubaldi F, Borini A. Vaginal parturition decreases recurrence of endometriosis. Fertil Steril. 2010;94(3):850–5.

    PubMed  Google Scholar 

  173. Parazzini F, Chiaffarino F, Surace M, Chatenoud L, Cipriani S, Chiantera V, et al. Selected food intake and risk of endometriosis. Hum Reprod. 2004;19:1755–9.

    CAS  PubMed  Google Scholar 

  174. Kidd PM. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern Med Rev. 2007;12:207–27.

    PubMed  Google Scholar 

  175. Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 1990;186:1–85.

    CAS  PubMed  Google Scholar 

  176. Harel Z, Biro FM, Kottenhahn RK, Rosenthal SL. Supplementation with omega-3 polyunsaturated fatty acids in the management of dysmenorrhea in adolescents. Am J Obstet Gynecol. 1996;174:1335–8.

    CAS  PubMed  Google Scholar 

  177. Kaneda N, Nagata C, Kabuto M, Shimizu H. Fat and fiber intakes in relation to serum estrogen concentration in premenopausal Japanese women. Nutr Cancer. 1997;27:279–83.

    CAS  PubMed  Google Scholar 

  178. Armstrong BK, Brown JB, Clarke HT, Crooke DK, Hähnel R, Masarei JR, et al. Diet and reproductive hormones: a study of vegetarian and nonvegetarian postmenopausal women. J Natl Cancer Inst. 1981;67:761–7.

    CAS  PubMed  Google Scholar 

  179. Longcope C, Gorbach S, Goldin B, et al. The effect of a low fat diet on estrogen metabolism. J Clin Endocrinol Metab. 1987;64:1246–50.

    CAS  PubMed  Google Scholar 

  180. Missmer SA, Chavarro JE, Malspeis S, Bertone-Johnson ER, Hornstein MD, Spiegelman D, et al. A prospective study of dietary fat consumption and endometriosis risk. Hum Reprod. 2010;25:1528–35.

    CAS  PubMed Central  PubMed  Google Scholar 

  181. Trabert B, Peters U, De Roos AJ, Scholes D, Holt VL. Diet and risk of endometriosis in a population-based case–control study. Br J Nutr. 2011;105(3):459–67.

    CAS  PubMed Central  PubMed  Google Scholar 

  182. Dhillon PK, Holt VL. Recreational physical activity and endometrioma risk. Am J Epidemiol. 2003;158:156–64.

    PubMed  Google Scholar 

  183. Missmer SA, Cramer DW. The epidemiology of endometriosis. Obstet Gynecol Clin North Am. 2003;30:1–19.

    PubMed  Google Scholar 

  184. Vitonis AF, Hankinson SE, Hornstein MD, Missmer SA. Adult physical activity and endometriosis risk. Epidemiology. 2010;21(1):16–23.

    PubMed Central  PubMed  Google Scholar 

  185. Signorello LB, Harlow BL, Cramer DW, Spiegelman D, Hill JA. Epidemiologic determinants of endometriosis: a hospital-based case–control study. Ann Epidemiol. 1997;7:267–741.

    CAS  PubMed  Google Scholar 

  186. Vitonis AF, Maruti SS, Se H, Hornstein MD, Missmer SA. Adolescent physical activity and endometriosis risk. J Endometriosis. 2009;1:157–63.

    Google Scholar 

  187. Crain DA, Janssen SJ, Edwards TM, Heindel J, Ho SM, Hunt P, et al. Female reproductive disorders: the roles of endocrine- disrupting compounds and developmental timing. Fertil Steril. 2008;90(4):911–40.

    CAS  PubMed Central  PubMed  Google Scholar 

  188. Gilbert SF. Mechanisms for the environmental regulation of gene expression: ecological aspects of animal development. J Biosci. 2005;30:65–74.

    CAS  PubMed  Google Scholar 

  189. Bumey RO, Giudice LC. The pathogenesis of endometriosis. In: Nezhat’s operative gynecologic laparoscopy and hysteroscopy. 3rd ed. New York: Cambridge University Press; 2008. p. 251–7.

    Google Scholar 

  190. Dl A, Foster WG. The link between environmental toxicant exposure and endometriosis. Front Biosci. 2008;13:1578–93.

    Google Scholar 

  191. Kl B-T, Yeaman GR, Crispens MA, Igarashi TM, Osteen KG. Dioxin may promote inflammation-related development of endometriosis. Fertil Steril. 2008;89(5 suppl):1287–98.

    Google Scholar 

  192. Herington JL, Bruner-Tran KL, Lucas JA, Osteen KG. Immune interactions in endometriosis. Expert Rev Clin Immunol. 2011;7:611–26.

    PubMed Central  PubMed  Google Scholar 

  193. Schaefer WR, Hermann T, Meinhold-Heerlein I, Deppert WR, Zahradnik HP. Exposure of human endometrium to environmental estrogens, antiandrogens, and organochlorine compounds. Fertil Steril. 2000;74:558–63.

    CAS  PubMed  Google Scholar 

  194. Quaranta MG, Porpora MG, Mattioli B, Giordani L, Libri I, Ingelido AM, et al. Impaired NK-cell-mediated cytotoxic activity and cytokine production in patients with endometriosis: a possible role for PCBs and DDE. Life Sci. 2006;79:491–8.

    CAS  PubMed  Google Scholar 

  195. Cooney MA, Buck Louis GM, Hediger ML, Vexler A, Kostyniak PJ. Organochlorine pesticides and endometriosis. Reprod Toxicol. 2010;30:365–9.

    CAS  PubMed  Google Scholar 

  196. Cobellis L, Latini G, De Felice C, Razzi S, Paris I, Ruggieri F, et al. High plasma concentrations of di-(2-ethylhexyl)-phthalate in women with endometriosis. Hum Reprod. 2003;18:1512–5.

    CAS  PubMed  Google Scholar 

  197. Reddy BS, Rozati R, Reddy S, Kodampur S, Reddy P, Reddy R. High plasma concentrations of polychlorinated biphenyls and phthalate esters in women with endometriosis: a prospective case control study. Fertil Steril. 2006;85:775–9.

    CAS  PubMed  Google Scholar 

  198. Buck Louis GM, Weiner JM, Whitcomb BW, Sperrazza R, Schisterman EF, Lobdell DT, et al. Environmental PCB exposure and risk of endometriosis. Hum Reprod. 2005;20:279–85.

    CAS  Google Scholar 

  199. Buck Louis GM, Chen Z, Peterson CM, Hediger ML, Croughan MS, Sundaram R, et al. Persistent lipophilic environmental chemicals and endometriosis : the ENDO Study. Environ Health Perspect. 2012;120(6):811–6.

    CAS  PubMed  Google Scholar 

  200. Myllymaki SA, Haavisto TE, Brokken LJ, Viluksela M, Toppari J, Paranko J. In utero and lactational exposure to TCDD; steroidogenic outcomes differ in male and female rat pups. Toxicol Sci. 2005;88:534–44.

    CAS  PubMed  Google Scholar 

  201. Pesonen SA, Haavisto TE, Viluksela M, Toppari J, Paranko J. Effects of in utero and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on rat follicular steroidogenesis. Reprod Toxicol. 2006;22:521–8.

    CAS  PubMed  Google Scholar 

  202. Wormke M, Stoner M, Saville B, Safe S. Crosstalk between estrogen receptor alpha and the aryl hydrocarbon receptor in breast cancer cells involves unidirectional activation of proteasomes. FEBS Lett. 2000;478:109–12.

    CAS  PubMed  Google Scholar 

  203. Osteen KG, Bruner-Tran KL, Eisenberg E. Reduced progesterone action during endometrial maturation: a potential risk factor for the development of endometriosis. Fertil Steril. 2005;83:529–37.

    CAS  PubMed  Google Scholar 

  204. Fazleabas AT, Brudney A, Chai D, Langoi D, Bulun SE. Steroid receptor and aromatase expression in baboon endometriotic lesions. Fertil Steril. 2003;80 Suppl 2:820–7.

    PubMed  Google Scholar 

  205. Hudelist G, Keckstein J, Czerwenka K, Lass H, Walter I, Auer M, et al. Estrogen receptor beta and matrix metalloproteinase 1 are coexpressed in uterine endometrium and endometriotic lesions of patients with endometriosis. Fertil Steril. 2005;84 Suppl 2:1249–56.

    CAS  PubMed  Google Scholar 

  206. Daxinger L, Whitelaw E. Understanding transgenerational epigenetic inheritance via the gametes in mammals. Nat Rev Genet. 2012;13:153–62.

    CAS  PubMed  Google Scholar 

  207. Calkins K, Devaskar SU. Fetal origins of adult disease. Curr Probl Pediatr Adolesc Health Care. 2011;41(6):158–76.

    PubMed  Google Scholar 

  208. Genuis SJ. The chemical erosion of human health: adverse environmental exposure and in-utero pollution- determinants of congenital disorders and chronic disease. J Perinat Med. 2006;34:185–95.

    CAS  PubMed  Google Scholar 

  209. Taylor HS M.D. Endocrine disruptors affect developmental programming of HOX gene expression. Fertil Steril. 2008;89(1):e57–8.

    PubMed Central  PubMed  Google Scholar 

  210. Takahashi O, Oishi S. Disposition of orally administered 2,2-Bis (4-hydroxyphenyl) propane (Bisphenol A) in pregnant rats and the placental transfer to fetuses. Environ Health Perspect. 2000;108:931–5.

    CAS  PubMed Central  PubMed  Google Scholar 

  211. Zalko D, Soto AM, Dolo L, Dorio C, Rathahao E, Debrauwer L, et al. Biotransformations of bisphenol A in a mammalian model: answers and new questions raised by low-dose metabolic fate studies in pregnant CDI mice. Environ Health Perspect. 2003;111:309–19.

    CAS  PubMed Central  PubMed  Google Scholar 

  212. Oesterheld J. A review of developmental aspects of cytochrome P450. J Child Adolesc Psychopharm. 1998;8:161–74.

    CAS  Google Scholar 

  213. Kreuzer PE, Csanady GA, Baur C, Kessler W, Papke O, Greim H, et al. 2,3,7,8,-tetrachlorodibenzo-p-dioxin (TCDD) and congeners in infants. A toxicokinetic model of human lifetime body burden by TCDD with special emphasis on its uptake by nutrition. Arch Toxicol. 1997;71:383–400.

    CAS  PubMed  Google Scholar 

  214. Jorissen J. Literature review: outcomes associated with postnatal exposure to polychlorinated biphenyls (PCBs) via breast milk. Adv Neonatal Care. 2007;7(5):230–7.

    PubMed  Google Scholar 

  215. Boersema ER, Lanting CI. Environmental exposure to polychlorinated biphenyls (PCBs) and dioxins. Consequences for longterm neurological and cognitive development of the child lactation. Adv Exp Med Biol. 2000;478:271–87.

    Google Scholar 

  216. Lee SY, Kim MT, Kim SW, Song MS, Yoon SJ. Effect of lifetime lactation on breast cancer risk: a Korean women’s cohort study. Int J Canc. 2003;105:390–3.

    CAS  Google Scholar 

  217. Daniels JL, Jen-Pan I, Jones R, Anderson S, Patterson DG, Needham LL, et al. Individual characteristics associated with PBDE levels in U.S. human milk samples. Environ Health Perspect. 2010;118(1):155–60.

    CAS  PubMed Central  PubMed  Google Scholar 

  218. Miyata H, Takenaka T, Nakao T, Aozasa O, Ohta S, Fujimine Y, et al. Investigation of the main source of halogenated environmental pollutants in human breast milk (The Third Report)- Influence by fasting. Organohalogen Comp. 2006;68:145–8.

    Google Scholar 

  219. LaKind JS. Recent global trends and physiologic origins of dioxins and furans in human milk. J Expo Sci Environ Epidemiol. 2007;17(6):510–24.

    CAS  PubMed  Google Scholar 

  220. Anderson RC, Anderson JH. Acute respiratory effects if diaper emissions. Arch Environ Health. 1999;54(5):353.

    CAS  PubMed  Google Scholar 

  221. Sathyanarayana S, Karr CJ, Lozano P, Brown E, Calafat AM, Liu F, et al. Baby care products: possible sources of infant phthalate exposure. Pediatrics. 2008;121(2):e260–8.

    PubMed  Google Scholar 

  222. Curl C, Fenske RA, Elgethun K. Organophosphorus pesticide exposure of urban and suburban preschool children with organic and conventional diets. Environ Health Perspect. 2003;111(3):377–82.

    CAS  PubMed Central  PubMed  Google Scholar 

  223. Kimbrell A. Fatal harvest: the tragedy of industrial agriculture. Washington: Foundation for Deep Ecology and Island Press; 2002. p. 211.

    Google Scholar 

  224. Zeligs MA. Diet and estrogen status: the cruciferous connection. J Med Food. 1998;1(2):67–82.

    CAS  Google Scholar 

  225. Estrogenic agents leach from dental sealant. Science News April 11, 1996;49:214.

    Google Scholar 

  226. Buckley JD, Meadows AT, Kadin ME, Le Beau MM, Siegel S. Pesticide exposures in children with non Hodgkin’s Lymphoma. Cancer. 2000;89(11):2315–21.

    CAS  PubMed  Google Scholar 

  227. Kokcu A. Relationship between endometriosis and cancer from current perspective. Arch Gynecol Obstet. 2011;284(6):1473–9.

    PubMed  Google Scholar 

  228. Frisch RE. Body fat, menarche and fertility. Hum Reprod. 1987;2(6):521–33.

    CAS  PubMed  Google Scholar 

  229. Stark O, Peckham CS, Moynihan C. Weight and age at menarche. Arch Dis Child. 1989;64:383–7.

    CAS  PubMed Central  PubMed  Google Scholar 

  230. Diamond F. The function of adipose tissue. Growth Genet Horm. 2002;18(2):17–22.

    Google Scholar 

  231. Chavarro JE, Peterson KE, Sobol AM, Wiecha JL, Gortmaker SL. Effect of a school-based obesity-prevention on menarche. Cancer Causes Control. 2005;16:1245–52.

    PubMed  Google Scholar 

  232. Buck Louis GM, Hediger ML, Peńa JB. Intrauterine exposures and risk of endometriosis. Hum Reprod. 2007;22:3232–6.

    PubMed  Google Scholar 

  233. Vitonis AF, Baer HJ, Hankinson SE, Laufer MR, Missmer SA. A prospective study of body size during childhood and early adulthood and the incidence of endometriosis. Hum Reprod. 2010;25:1325–34.

    PubMed Central  PubMed  Google Scholar 

  234. Somigliana E, Vigano P, Abbiati A, Paffoni A, Benaglia L, Vercellini P, et al. Perinatal environment and endometriosis. Gynecol Obstet Invest. 2011;72:135–40.

    PubMed  Google Scholar 

  235. Wolff EF, Sun L, Hediger ML, Sundaram R, Peterson CM, Chen Z, et al. In utero exposures and endometriosis: the Endometriosis, Natural History, Disease, Outcome(ENDO) Study. Fertil Steril. 2013;99(3):790–5.

    CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dr. Zekai Tahir Burak Women Health Care, Education and Research Hospital Ankara, Ankara, Turkey

    Ebru H. Biberoglu

  2. Gazi University Medical School, Professor of Obstetrics and Gynecology, Gynecological Endocrinology and Infertility Unit Besevler, Ankara, Turkey

    Kutay O. Biberoglu

Authors
  1. Ebru H. Biberoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kutay O. Biberoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ebru H. Biberoglu .

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynecology, Tottori University Faculty of Medicine, Yonago, Tottori, Japan

    Tasuku Harada

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Japan

About this chapter

Cite this chapter

Biberoglu, E.H., Biberoglu, K.O. (2014). Prevention of Endometriosis. In: Harada, T. (eds) Endometriosis. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54421-0_18

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-54421-0_18

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-54420-3

  • Online ISBN: 978-4-431-54421-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation